Monoclonal antibodies expressed by ATCC PTA-5643 for the manufacture of a medicament for the treatment of cancer

摘要

Disclosed is the use of a monoclonal antibody or antigen binding fragment thereof which has the identifying characteristics of a monoclonal antibody encoded by a clone deposited with the ATCC as accession number PTA-5643, for the manufacture of a composition for treating a human tumor in a mammal, to reduce said mammal's tumor burden, whereby disease progression is delayed and/or survival is extended; and wherein said tumor expresses an antigen which specifically binds to a monoclonal antibody or antigen binding fragment thereof which has the identifying characteristics of a monoclonal antibody encoded by a clone deposited with the ATCC as accession number PTA-5643.